A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moxifloxacin Impurity J | Moxifloxacin Impurity J. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid. CAS No. 112811-72-0. Molecular formula: C14H11F2NO4. Mole weight: 295.24. Catalog: APB112811720. |  |
| Moxifloxacin Impurity Q | Moxifloxacin Impurity Q. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1329836-33-0. Molecular formula: C16H15F2NO4. Mole weight: 323.3. Catalog: APB1329836330. | |
| Moxifloxacin Impurity V | Moxifloxacin Impurity V. Uses: For analytical and research use. Group: Impurity standards. CAS No. 112811-67-3. Molecular formula: C15H15F3O6. Mole weight: 348.27. Catalog: APB112811673. | |
| Moxifloxacin Impurity Z | Moxifloxacin Impurity Z. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 154093-72-8. Molecular formula: C13H9F2NO4. Mole weight: 281.21. Catalog: APB154093728. | |
| Moxifloxacin N-Sulfate Disodium Salt | A sulfometabolite of Moxifloxacin. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Moxifloxacin Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound F | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin RR-Isomer HCl | Moxifloxacin RR-Isomer HCl. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1394029-14-1. Molecular formula: C21H25ClFN3O4. Mole weight: 437.9. Catalog: APB1394029141. | |
| Moxifloxacin (Standard) | Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 151096-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-66011AR. |  |
| Moxilubant | Moxilubant (CGS-25019C;LTB-019) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2 - 4 nM. Moxilubant can be used for cancer research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CGS 25019C free base. CAS No. 146978-48-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-106929. | |
| Moxisylyte hydrochloride | Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Thymoxamine hydrochloride. CAS No. 964-52-3. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-B1435. | |
| Moxisylyte Hydrochloride | >99% (TLC), powder. Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: Moxilite, Thymoxamine, [2-(4-Acetoxy-2-isopropyl-5-methylphenoxy)ethyl]dimethylamine, Carvacrol, 5-[2-(dimethylamino)ethoxy]-, acetate (ester) (8CI), 6-Acetoxythymol 2-(dimethylamino)ethyl ether, Moxisylite, Moxisylyt, 4-(2-Dimethylaminoethoxy)-2-methyl-5-isopropylphenyl acetate, Timoxamina, 4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetate, Arlytene, Sympal, Carvacrol, 5-[2-(dimethylamino)ethoxy]-, acetate (6CI,7CI), [(6-Acetoxythymoxy)ethyl]dimethylamine, Moxisylyte, 5-[2-(Dimethylamino)ethoxy]carvacrol acetate, Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester) (9CI),Thymoxamine Hydrochloride, Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, 1-acetate. | |
| Moxonidine | Moxonidine (BDF5895) is an imidazoline type 1 receptor (I1-R) selective agonist and antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895. CAS No. 75438-57-2. Pack Sizes: 10 mM * 1 mL; 100 mg. Product ID: HY-B0374. | |
| Moxonidine | Moxonidine is an antihypertensive agent. Group: Biochemicals. Alternative Names: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens. Grades: Highly Purified. CAS No. 75438-57-2. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Moxonidine-[d4] | Moxonidine-[d4] is the labelled analogue of Moxonidine. Moxonidine is a selective agonist at the imidazoline receptor subtype (I1). It binds with much greater affinity to the imidazoline I1-receptor than to the α2-receptor while clonidine binds to both receptors with equal affinity. Synonyms: Moxonidine D4; 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl-d4)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline-d4. Grade: 95% by HPLC; 95% atom D. CAS No. 1794811-52-1. Molecular formula: C9H8D4ClN5O. Mole weight: 245.7. |  |
| Moxonidine hydrochloride | Moxonidine hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 75536-04-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Moxonidine hydrochloride | Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895 hydrochloride. CAS No. 75536-04-8. Pack Sizes: 10 mM * 1 mL; 5 mg. Product ID: HY-B0374A. | |
| Moxonidine hydrochloride | ?98%. Group: Fluorescence/luminescence spectroscopy. | |
| Mozavaptan | 5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine. anticancer agent. CAS No. 137975-06-5. Product ID: 8-04766. Molecular formula: C27H29N3O2. Mole weight: 427.54. |  |
| MP265 | MP265 (4-Chlorobenzyl carbamimidothioate hydrochloride) is a structural analogue of A22 but is less toxic. MP265 is a MreB inhibitor[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: 4-Chlorobenzyl carbamimidothioate hydrochloride. CAS No. 544-47-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131583. | |
| MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 ( PDK1 ) inhibitor. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PDK1 inhibitor. CAS No. 1001409-50-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14440. | |
| MPAC-Br | MPAC-Br. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 3-[4-(Bromomethyl)phenyl]7-(diethylamino)-coumarin. Product Category: Other Fluorophores. Appearance: Yellow to brown crystals. CAS No. 177093-58-2. Molecular formula: C20H20BrNO2. Mole weight: 386.28. Purity: 98%+. IUPACName: 3-[4-(bromomethyl)phenyl]-7-(diethylamino)chromen-2-one. Canonical SMILES: CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=CC=C(C=C3)CBr. Product ID: ACM177093582-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: 3-[4-(Bromomethyl)phenyl]-7-(diethylamino)coumarin, Mac Brunson. |  |
| MPC-3100 | MPC-3100 is a recently discovered fully synthetic purine-based Hsp90 Inhibitor exhibiting anticancer properties. Group: Biochemicals. Alternative Names: (2S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone. Grades: Highly Purified. CAS No. 958025-66-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| MPC 6827 hydrochloride | MPC 6827 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 917369-31-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MPDC | MPDC. Group: Biochemicals. Grades: Purified. CAS No. 159262-32-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| mPEG10K-Propionaldehyde | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG10K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Molecular formula: average Mn 10000. |  |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 10000. | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| m-PEG12-acid | m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2135793-73-4. Pack Sizes: 50 mg; 100 mg; 250 mg. Product ID: HY-135820. | |
| mPEG12-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| m-PEG12-amine | m-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. m-PEG12-amine is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1977493-48-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-140227. | |
| mPEG12-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 12000. | |
| mPEG12-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 559.7g/mol. Mole weight: C25H53NO12. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CN. InChI= 1S / C25H53NO12 / c1-27-4-5-29-8-9-31-12-13-33-16-17-35 -20-21-37-24-25-38-23-22-36-19-18-34- 15-14-32-11-10-30-7-6-28-3-2-26 / h2-26H | |
| mPEG12-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG12-Hydroxyl. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 560.7g/mol. Mole weight: C25H52O13. [H]OCCOC. 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. XNWFRZJHXBZDAG-UHFFFAOYSA-N. | |
| mPEG12-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG12-PA, methoxy-PEG-Propionic acid. OC(CCOCCOC)=O. 1S/C6H12O4/c1-9-4-5-10-3-2-6 (7)8/h2-5H2, 1H3, (H, 7, 8). KWMXBFIAGYXCCC-UHFFFAOYSA-N. | |
| mPEG12-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Molecular formula: 576.7g/mol. Mole weight: C25H52O12S. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CS. InChI= 1S / C25H52O12S / c1-26-2-3-27-4-5-28-6-7-29-8-9-30-10- 11-31-12-13-32-14-15-33-16-17-34-18-1 9-35-20-21-36-22-23-37-24-25-38 / h38H, | |
| mPEG16-NH2 | mPEG16-NH2. Group: Polymers. CAS No. 907577-50-8. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 735.9g/mol. Mole weight: C33H69NO16. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC COCCOCCOCCOCCN. InChI= 1S / C33H69NO16 / c1-35-4-5-37-8-9-39-12-13-41-16-17-43 -20-21-45-24-25-47-28-29-49-32-33-50- 31-30-48-27-26-46-23-22-44-19-18-42-1 5-14-40-11-10-38-7-6-36-3-2-34 / h2-34H2, 1H3. AZTFEVBTZHBNCX-UHFFFAOYSA-N. | |
| MPEG-2000-DSPE | MPEG-2000-DSPE was used to study stability and biodistribution and toxicity of lung-specific liposomal antitubercular drugs. Group: Biochemicals. Grades: Highly Purified. CAS No. 147867-65-0. Pack Sizes: 100mg, 250mg. Molecular Formula: (C2H4O)nC43H84NO10P. US Biological Life Sciences. | Worldwide |
| mPEG 2000 DSPE sodium salt | Sodium [(2R)-2,3-di(octadecanoyloxy)propyl] 2-(2-methoxyethoxycarbonylamino)ethyl phosphate, MPEG-2000-DSPE. Grades: >95% (HPLC). CAS No. 147867-65-0. Product ID: 8-04938. Molecular formula: C45H87NNaO11P C91H180NO33P. Mole weight: 1847.36. | |
| mPEG20K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| mPEG20K-MAL | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG20K-Silane | average Mn 20000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG20K-Silane | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| mPEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| mPEG20K-Succinimidyl Carboxymethyl Ester | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG2K-MAL | average Mn 2,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG2K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 2000. | |
| mPEG2k-PLA2k-PAE9k | mPEG2k-PLA2k-PAE9k. Synonyms: methoxy polyethylene glycol-Poly(D,L-lactide)-Poly(b-amino esters). Product ID: MSMN-057. Category: Raw Materials. |  |
| mPEG2K-Thioctic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 2000. | |
| mPEG2K-Thioctic acid | average Mn 2000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG30K-Succinimidyl Carboxymethyl Ester | average Mn 30,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG30K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 30000. | |
| MPEG ~350 (Methoxypolyethylene Glycol) | Methoxypolyethylene Glycol of with an average molecular mass of 350. Methoxypolyethylene Glycol (MPEG) is used in various applications such as micelles for drug delivery as well as in modifications of therapeutic proteins to improve their pharmacokinetics. Group: Biochemicals. Grades: Highly Purified. CAS No. 9004-74-4. Pack Sizes: 50g, 100g. Molecular Formula: CH3O(CH2CH2O)nH, Molecular Weight: US Biological Life Sciences. | Worldwide |
| m-PEG3-NHS carbonate | m-PEG3-NHS carbonate. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 477775-77-2. Molecular formula: C12H19NO8. Mole weight: 305.28. Purity: 95%+. Product ID: ACM477775772. Alfa Chemistry ISO 9001:2015 Certified. | |
| mPEG40K-MAL | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG40K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| mPEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| mPEG40K-Succinimidyl Carboxymethyl Ester | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| M-PEG4-aldehyde | M-PEG4-aldehyde. Uses: Designed for use in research and industrial production. Product Category: Alkyl PEG Linkers. CAS No. 197513-96-5. Molecular formula: C10H20O5. Mole weight: 220.26. Purity: 95%+. Product ID: ACM197513965. Alfa Chemistry ISO 9001:2015 Certified. | |
| m-PEG4-NHS ester | m-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Uses: Scientific research. Group: Signaling pathways. CAS No. 622405-78-1. Pack Sizes: 100 mg; 250 mg; 500 mg. Product ID: HY-124323. | |
| mPEG5-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG5-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| mPEG5K-Alkyne | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Alkyne, Methoxy-PEG-Alkyne. Molecular formula: average Mn 5000. | |
| mPEG5K-Alkyne | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG5K-Hydrazide | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
Our database is helping our users find suppliers everyday.
